Nano Letters · 2012 · 100 citations · 24 references
EngineeringBiotechnologyCancer BiologyBiosensorsNanobiotechnologyNanomaterialsCancer BiomarkersCancer NanomedicineCell-based BiosensorsCell-nanoparticle InteractionsNanomaterial-based BiosensorsNanosensorsDiagnostic NanoprobesElectrochemical AssaysHydrogen EvolutionHydrogen Evolution ReactionIn Situ SensingNanoparticle-based BiosensorsNanoparticle-based SensingNanoparticles
Here we present a new strategy for a simple and fast detection of cancer circulating cells (CTCs) using nanoparticles. The human colon adenocarcinoma cell line (Caco2) was chosen as a model CTC. Similarly to other adenocarcinomas, colon adenocarcinoma cells have a strong expression of EpCAM, and for this reason this glycoprotein was used as the capture target. We combine the capturing capability of anti-EpCAM functionalized magnetic beads (MBs) and the specific labeling through antibody-modified gold nanoparticles (AuNPs), with the sensitivity of the AuNPs-electrocatalyzed hydrogen evolution reaction (HER) detection technique. The fully optimized process was used for the electrochemical detection of Caco2 cells in the presence of monocytes (THP-1), other circulating cells that could interfere in real blood samples. Therefore we obtained a novel and simple in situ-like sensing format that we applied for the rapid quantification of AuNPs-labeled CTCs in the presence of other human cells.
24
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Sunitha Nagrath, Lecia V. Sequist, Shyamala Maheswaran et al. · Nature · 2007 · 3.5K citations · Full text
Medicine, Cancer Biology, Oncology +15
Frequent EpCam protein expression in human carcinomas
Philip Went, Alessandro Lugli, Sandra Meier et al. · Human Pathology · 2004 · 826 citations